DAZIDAMINE
UNII J191YXB819

Substance Identification & Data

This profile provides standardized clinical and technical data for Dazidamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J191YXB819.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 75522-73-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

J191YXB819

CAS Registry Number

75522-73-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAZIDAMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H23N3S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VPMZGRVNLHDREW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C76799

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

205962

Unique identification number in the NCBI database of chemical substances.

INN ID

5038

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1n(c(c2ccccc12)SCCCN(C)C)Cc3ccccc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dazidamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.